跳至主要内容
临床试验/NCT02465827
NCT02465827已完成4 期

Selective Blocks for Total Knee Arthroplasty

Bispebjerg Hospital0 个研究点目标入组 75 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
75
主要终点
Dynamic pain (pain upon movement) quantified as area-under-the-curve (AUC) 24-hours post-operatively

研究概览

简要总结

The investigators aimed to evaluate the efficacy of selective low volume ultrasound-guided blockades of the saphenous and obturator nerves on dynamic and rest pain 24-hours post-operatively for patients undergoing unilateral primary total knee arthroplasty.

详细描述

A femoral nerve block is the recommended strategy in many surgical centers to supplement multimodal analgesic regime following total knee arthroplasty (TKA) (i.e. both for spinal and general anesthesia). However, a femoral nerve block will often result in quadriceps paralysis, and this will increase the risk for the patient to fall as long as the femoral block have effect. Thus, the search for sensory nerve blocks to stop pain after TKA is a very interesting topic. The saphenous nerve is a purely sensory nerve, and the posterior branch of the obturator nerve is a mixed nerve, where the motor component only affects part of the adductor major muscle.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists' physical classification I-III
  • Age ≥ 18 years undergoing primary unilateral total knee arthroplasty

排除标准

  • Inability to cooperate
  • Inability to speak and understand Danish
  • Allergy to any drugs used in the study
  • Drug or alcohol abuse
  • Pregnancy or nursing
  • Opioid abusers

研究组 & 干预措施

Saphenous and obturator nerve block

Active Comparator

5 ml of ropivacaine 0.75% for the saphenous nerve and 10 ml of ropivacaine 0,75% for the obturator nerve block.

Ropivacaine 0.75% for nerve blockades for both nerves mentioned.

干预措施: nerve block with ropivacaine (Drug)

Saphenous nerve block

Active Comparator

5 ml of ropivacaine 0.75% for the saphenous nerve and 10 ml of isotonic saline for the obturator nerve block.

Ropivacaine 0.75% for the saphenous nerve block and saline for the obturator nerve block

干预措施: nerve block with ropivacaine and with saline (Drug)

Placebo nerve block

Placebo Comparator

5 ml of isotonic saline for the saphenous nerve and 10 ml of isotonic saline for the obturator nerve block.

Saline for nerve blockades for both nerves mentioned.

干预措施: nerve block with saline (Drug)

结局指标

主要结局

Dynamic pain (pain upon movement) quantified as area-under-the-curve (AUC) 24-hours post-operatively

时间窗: 24 hours

NRS 0-10

次要结局

  • Pain at rest quantified as area-under-the-curve (AUC) 24-hours post-operatively(24 hours)
  • Length of stay in recovery and hospital(72 hours)
  • Time to first mobilization(24 hours)
  • Total opioid consumption(24 hours)
  • Number of clinical complications(72 hours)
  • Nausea and vomiting(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jens Borglum Neimann

Ass professor, PhD

Bispebjerg Hospital

相似试验